Skip to content

Clinical trials

Observational Influenza, Human trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Influenza, Human Phase: Observational Country / region: United States Clear all

115 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20047
20052
20063
20074
20084
200912
20105
20118
20123
20134
20149
20158
20174
20185
20193
20205
20215
20228
20237
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Recruiting10
Terminated8
Active, not recruiting6
Unknown status5
Withdrawn5
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)17
University of Wisconsin, Madison6
Henry M. Jackson Foundation for the Advancement of Military Medicine3
MedImmune LLC3
Pfizer3
Sanofi Pasteur, a Sanofi Company3
Seqirus3
American Pharmacists Association Foundation2
Boston Children's Hospital2
Evidation Health2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Influenza, Human115
COVID-1917
Respiratory Tract Infections10
Coronavirus Infections9
Infections5
Pneumonia5
Orthomyxoviridae Infections4
Respiratory Syncytial Virus Infections4
Virus Diseases4
Common Cold3

Trials

Showing 1 to 25 of 115. Each trial links to its page on Pharma Observatory.

15 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.